FGF-401 - CAS 1708971-55-4
Catalog number: B0084-007362
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
Molecular Weight:
FGF-401 is an inhibitor of human fibroblast growth factor receptor 4 (FGFR4) (IC50= 1.9 nM) developed for the treatment of solid tumor.
Ordering Information
Catalog Number Size Price Stock Quantity
B0084-007362 10 mg $198 In stock
Bulk Inquiry
Brife Description:
An inhibitor of FGFR4
FGF401; FGF-401; FGF 401; roblitinib; N-[5-cyano-4-(2-methoxyethylamino)pyridin-2-yl]-7-formyl-6-[(4-methyl-2-oxopiperazin-1-yl)methyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide
DMSO: 6 mg/mL (Need Ultrasonic)
Store in a cool and dry place (or refer to the Certificate of Analysis).
Boiling Point:
852.1±65.0 ℃ at 760 Torr
1.39±0.1 g/cm3
Canonical SMILES:
1.Bile Acid Sequestration by Cholestyramine Mitigates FGFR4 Inhibition-Induced ALT Elevation.
Schadt HS;Wolf A;Mahl JA;Wuersch K;Couttet P;Schwald M;Fischer A;Lienard M;Emotte C;Teng CH;Skuba E;Richardson TA;Manenti L;Weiss A;Graus Porta D;Fairhurst RA;Kullak-Ublick GA;Chibout SD;Pognan F;Kluwe W;Kinyamu-Akunda J Toxicol Sci. 2018 May 1;163(1):265-278. doi: 10.1093/toxsci/kfy031.
The FGF19- fibroblast growth factor receptor (FGFR4)-βKlotho (KLB) pathway plays an important role in the regulation of bile acid (BA) homeostasis. Aberrant activation of this pathway has been described in the development and progression of a subset of liver cancers including hepatocellular carcinoma, establishing FGFR4 as an attractive therapeutic target for such solid tumors. FGF401 is a highly selective FGFR4 kinase inhibitor being developed for hepatocellular carcinoma, currently in phase I/II clinical studies. In preclinical studies in mice and dogs, oral administration of FGF401 led to induction of Cyp7a1, elevation of its peripheral marker 7alpha-hydroxy-4-cholesten-3-one, increased BA pool size, decreased serum cholesterol and diarrhea in dogs. FGF401 was also associated with increases of serum aminotransferases, primarily alanine aminotransferase (ALT), in the absence of any observable adverse histopathological findings in the liver, or in any other organs. We hypothesized that the increase in ALT could be secondary to increased BAs and conducted an investigative study in dogs with FGF401 and coadministration of the BA sequestrant cholestyramine (CHO). CHO prevented and reversed FGF401-related increases in ALT in dogs in parallel to its ability to reduce BAs in the circulation.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related FGFR Products

CAS 1125780-41-7 SKLB610

(CAS: 1125780-41-7)

SKLB610 is a VEGFR inhibitor that potently suppresses human tumor angiogenesis. SKLB610 inhibited angiogenesis-related tyrosine kinase VEGFR2, fibroblast growth...

CAS 939805-30-8 ACTB-1003

(CAS: 939805-30-8)

ACTB-1003 is an oral kinase inhibitor with multiple modes of action, targeting cancer mutations via FGFR inhibition FGFR1, angiogenesis through inhibition of VE...

CAS 1633044-56-0 FIIN-2

(CAS: 1633044-56-0)

FIIN-2 is a potent, selective, irreversible and the next-generation covalent FGFR inhibitor. FIIN-2 is the first inhibitor that can potently inhibit the prolife...

CAS 692737-80-7 Dovitinib lactate

Dovitinib lactate
(CAS: 692737-80-7)

Dovitinib, also referred as CHIR-258 or TKI258, is a potent receptor tyrosine kinase inhibitor (TKI) that selectively targets VEGFR, PDGFR, FGFR, CSF1R, c-KIT, ...

CAS 1234356-69-4 ARQ-087

(CAS: 1234356-69-4)

ARQ-087, also known as Derazantinib, is an oral fibroblast growth factor receptor (FGFR) inhibitor with antitumor property. FGFR plays a role in the regulation ...

E 3810 dihydrochloride

E 3810 dihydrochloride is a dual VEGFR/FGFR tyrosine kinase inhibitor. It suppresses the tumor angiogenesis and tumor cell proliferation via inhibiting VEGFR1, ...

CAS 9050-30-0 Heparan Sulfate

Heparan Sulfate
(CAS: 9050-30-0)

Heparan sulfate, a complex and linear polysaccharide in which the backbone is composed of repeating sulfated disaccharide units, exists as part of glycoproteins...

CAS 1708971-55-4 FGF-401

(CAS: 1708971-55-4)

FGF-401 is an inhibitor of human fibroblast growth factor receptor 4 (FGFR4) (IC50= 1.9 nM) developed for the treatment of solid tumor.

Chemical Structure

CAS 1708971-55-4 FGF-401

Quick Inquiry

Verification code

Featured Items